Kidney Diseases
-
Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases
Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development. Read MoreSep 11, 2017
-
Study tracks new end-stage renal disease therapy
Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease. Read MoreAug 7, 2014
-
Woman gives ultimate Valentine’s gift to her husband
Kim Duncan donated a kidney to her husband, Thomas, on Valentine’s Day last week. (photo by Daniel Dubois) For the nearly 25 years Thomas Duncan has been married, he was crowned the king of Valentine’s Day gift giving. Not this year however, says his wife, Kim, who… Read MoreFeb 14, 2013
-
Kidney dopamine regulates blood pressure, life span
Vanderbilt University Medical Center investigators have demonstrated that dopamine produced outside the brain – in the kidneys – is important for renal function, blood pressure regulation and life span. Read MoreAug 5, 2011